Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BMO Capital Maintains Outperform on Nuvei, Lowers Price Target to C$28

Author: Benzinga Newsdesk | March 07, 2024 10:17am
BMO Capital analyst James Fotheringham maintains Nuvei (TSX:NVEI) with a Outperform and lowers the price target from C$30 to C$28.

Posted In: TSX:NVEI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist